Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Due to Quetiapine's particulars and the promising receptor profile, we want to examine the
efficacy concerning relapse prevention of alcoholics suffering from persisting craving and/or
affective symptoms (persisting sleep disorder, persisting excitement, persisting depressive
symptoms, persisting anxiety symptoms) in comparison to matching placebo in a double-blind
pilot study.
We further want to compare the course of the above mentioned craving and affective symptoms
under medication with quetiapine / matching placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH